This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

V114

Merck & Co., Inc.

Drug Names(s): V-114, Pneumococcal Conjugate Vaccine, 15-valent Pneumococcal Conjugate Vaccine, PCV15

Description: V114 is a pneumococcal conjugate vaccine. Merck is testing both an aluminum-adjuvanted and non-adjuvanted version of the vaccine.


V114 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug